Infotrans
  • Ita
  • Eng
  • Esp
  • Por
  • Sobre nós
  • Informações gerais
    • Quem é uma pessoa transgênero?
    • Linguagens
    • Transfobia
    • Mitos e ideias falsas
  • Mapa de serviços
  • Saúde e bem estar
    • Prevenção e saúde transgênero
    • Infecções Sexualmente Transmissíveis (IST)
  • O processo de afirmação de gênero
    • O processo em poucas palavras
    • O papel do psicólogo
    • O papel do psiquiatra
    • Preservação da fertilidade
    • Tratamento hormonal
    • Tratamento cirúrgico
      • Introdução ao tratamento cirúrgico
      • Mamoplastia de aumento
      • Orquiectomia bilateral
      • Vaginoplastia com inversão peniana
      • Vaginoplastia intestinal
      • Masculinização do tórax
      • Histerectomia com anexectomia
      • Faloplastia
      • Feminilização da voz
    • Sexualidade
  • Direitos e proteção da identidade de gênero
    • O direito à retificação de documentos pessoais
    • O procedimento de retificação de gênero na Itália
    • Perguntas frequentes
    • Discriminação e intimidação de pessoas transgênero
    • Resenha legislativa
  • Boas práticas para profissionais
    • Boas práticas para profissionais - Introdução
    • Área Formação
    • Área sociomédica
    • Área Comunicação e informação
    • Área Trabalho
    • Área Sindicato
    • Área Jurídica
    • Área Institucional
  • Carreira "alias" universidade
  • Associações
  • Glossário
Infotrans

Augmentation mammoplasty

Who can undergo this surgery?

In Italy, people who match the following criteria can undergo breast augmentation surgery:

  •          18 years of age (for people under 18 years of age, both parents or legal tutors have to sign written consent to treatment)
  •           Demonstrates capacity to consent for the specific gender-affirming surgical intervention

Although it is not a fundamental requirement, feminizing hormone therapy lasting at least 6 months is recommended prior to breast augmentation surgery. The aim is to maximize breast growth in order to obtain better surgical (aesthetic) results. These requirements are indicated in the scientific publications listed in the "Bibliography" section.

When the necessary criteria for carrying out the surgery are met (see above), the person concerned must:

  • identify a specialized clinical center
  • schedule a medical consultation with the specialist to decide:
    • where to place the prosthesis (behind the pectoralis major muscle, under the mammary gland or partly behind the muscle and partly under the gland, the latter called dual plane breast augmentation)
    • the type of prosthesis and its dimensions
    • the location of the scar (around the breast areola, in the armpit or under the breast)

It is not necessary to stop oestrogen hormone therapy. However, interruption of hormonal treatment may be suggested, in some cases, as this therapy increases the risk of thrombosis associated with the operation. The interruption can vary from 2-4 weeks before surgery to 2-4 weeks after. In general, if you are taking any prescription medication, you should discuss it with your specialist. It may be necessary to stop taking it even several days before the surgery. Drug therapy may be resumed at the doctor's discretion.

Breast augmentation is a cosmetic surgery that allows you to increase the breasts by inserting silicone implants.
There are several techniques for performing breast augmentation which vary on:

  • the place where the prosthesis is placed (behind the pectoralis major muscle, under the mammary gland or partly behind the muscle and partly under the gland, the latter called dual plane breast augmentation)
  • the type of prosthesis
  • the location of the scar (around the breast areola, in the armpit or under the breast)

The technique used for this surgery is chosen on the basis of the characteristics of the person (height and size of the chest) and his expectations. The operation lasts 60-90 minutes and takes place under general anesthesia.

The surgical procedure is performed on a day-hospital basis or short hospital stay, depending on the characteristics of the person and post-operative recovery.

  • Pain and / or discomfort in the hours and days following the surgery are normal
  • A surgical bra must be worn for four weeks after the operation
  • In the first few days it is recommended to avoid raising your arms, making efforts with them and lifting loads
  • Walking without getting tired is recommended to prevent the risk of deep vein thrombosis
  • The first check-up visit with the surgeon is usually scheduled within the first week after the surgical procedure
  • After 4 weeks from the operation, it is generally possible to return to the usual activities.

 

Like any surgery, there is a risk of bleeding, infections and adverse reactions to anesthesia.
Other specific risks and complications of this surgery are: capsular contracture (the formation of a sort of scar around the prosthesis that can compress it causing deformity, pain or a hard texture of the breast), seroma (accumulation of fluid), displacement of the implants, rupture of the prosthesis, loss of sensation, prolonged pain after surgery, asymmetry between the two breasts, dissatisfaction with the aesthetic result obtained.
Correction of these complications may require further surgery.

National Health Service (NHS): it is possible to carry out this intervention at the expense of the NHS in a public facility (only in some regions).
Private care: at the discretion of the health provider.

Coleman E,  Radix AE, Bouman W,  et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022; Sep 6;23(Suppl 1):S1-S259.
Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903. Erratum in: J Clin Endocrinol Metab. 2018; 103(2): 699. J Clin Endocrinol Metab. 2018; 103(7): 2758-2759.

Infotrans é um projeto financiado pelo Programa Operativo Nacional Inclusão com a contribuição do Fundo Social Europeu 2014-2020

Infotrans

Contactos

Istituto Superiore di Sanità
Viale Regina Elena 299 - 00161 Roma
Número de IVA 03657731000
Código Fiscal 80211730587

E-mail: info@infotrans.it
Site institucional da ISS
ISSalute.it (em italiano)